Year |
Citation |
Score |
2015 |
Trad M, Gautheron A, Fraszczak J, Alizadeh D, Larmonier C, LaCasse CJ, Centuori S, Audia S, Samson M, Ciudad M, Bonnefoy F, Lemaire-Ewing S, Katsanis E, Perruche S, Saas P, et al. T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1. Biomed Research International. 2015: 891236. PMID 26491691 DOI: 10.1155/2015/891236 |
0.789 |
|
2014 |
Hanke NT, LaCasse CJ, Larmonier CB, Alizadeh D, Trad M, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15. European Journal of Immunology. 44: 2489-99. PMID 24777831 DOI: 10.1002/Eji.201343803 |
0.704 |
|
2012 |
Centuori SM, Trad M, LaCasse CJ, Alizadeh D, Larmonier CB, Hanke NT, Kartchner J, Janikashvili N, Bonnotte B, Larmonier N, Katsanis E. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells. Journal of Leukocyte Biology. 92: 987-97. PMID 22891289 DOI: 10.1189/Jlb.0911465 |
0.663 |
|
2011 |
LaCasse CJ, Janikashvili N, Larmonier CB, Alizadeh D, Hanke N, Kartchner J, Situ E, Centuori S, Har-Noy M, Bonnotte B, Katsanis E, Larmonier N. Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 187: 6310-7. PMID 22075702 DOI: 10.4049/Jimmunol.1101812 |
0.677 |
|
2011 |
Janikashvili N, LaCasse CJ, Larmonier C, Trad M, Herrell A, Bustamante S, Bonnotte B, Har-Noy M, Larmonier N, Katsanis E. Allogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia. Blood. 117: 1555-64. PMID 21123824 DOI: 10.1182/Blood-2010-06-288621 |
0.79 |
|
2008 |
Larmonier N, Janikashvili N, LaCasse CJ, Larmonier CB, Cantrell J, Situ E, Lundeen T, Bonnotte B, Katsanis E. Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors. Journal of Immunology (Baltimore, Md. : 1950). 181: 6955-63. PMID 18981115 DOI: 10.4049/Jimmunol.181.10.6955 |
0.795 |
|
2008 |
Golden JM, LaCasse CJ, Simova DV, Murphy TR, Kurt RA. Differential mediator production by dendritic cells upon toll-like receptor stimulation does not impact T cell cytokine expression. Immunology Letters. 118: 30-5. PMID 18403024 DOI: 10.1016/J.Imlet.2008.02.011 |
0.478 |
|
2008 |
Larmonier N, Cantrell J, Lacasse C, Li G, Janikashvili N, Situ E, Sepassi M, Andreansky S, Katsanis E. Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression. Journal of Leukocyte Biology. 83: 1049-59. PMID 18174364 DOI: 10.1189/Jlb.0907635 |
0.813 |
|
Show low-probability matches. |